【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Interventional Neurology Overview 13
3 Products under Development 14
3.1 Interventional Neurology – Pipeline Products by Stage of Development 14
3.2 Interventional Neurology – Pipeline Products by Segment 15
3.3 Interventional Neurology – Pipeline Products by Territory 17
3.4 Interventional Neurology – Pipeline Products by Regulatory Path 18
3.5 Interventional Neurology – Pipeline Products by Estimated Approval Date 19
3.6 Interventional Neurology – Ongoing Clinical Trials 20
4 Interventional Neurology – Pipeline Products under Development by Companies 21
4.1 Interventional Neurology Companies – Pipeline Products by Stage of Development 21
4.2 Interventional Neurology – Pipeline Products by Stage of Development 24
5 Interventional Neurology Companies and Product Overview 27
5.1 Alcyone Lifesciences, Inc. Company Overview 27
5.1.1 Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Aneuclose LLC Company Overview 28
5.2.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Technologies Company Overview 30
5.3.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Arterain Medical Inc. Company Overview 31
5.4.1 Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Avantec Vascular Corporation Company Overview 32
5.5.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 Cibiem, Inc. Company Overview 34
5.6.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Codman & Shurtleff, Inc. Company Overview 37
5.7.1 Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 Collagen Matrix, Inc. Company Overview 39
5.8.1 Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Cordis Corporation Company Overview 40
5.9.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 CranioVation Company Overview 42
5.10.1 CranioVation Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Dartmouth College Company Overview 43
5.11.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 DePuy Companies Company Overview 45
5.12.1 DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 45
5.13 EchoGuide Medical, Inc. Company Overview 55
5.13.1 EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.14 EKOS Corporation Company Overview 56
5.14.1 EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.15 Gaudi Vascular, Inc. Company Overview 57
5.15.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 59
5.16.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 59
5.17 Hibernia Medical Company Overview 61
5.17.1 Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 Insera Therapeutics, LLC Company Overview 62
5.18.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 InspireMD, Inc. Company Overview 64
5.19.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.20 ITGI Medical Ltd. Company Overview 66
5.20.1 ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.21 Lazarus Effect, Inc Company Overview 67
5.21.1 Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.22 Medikit Co., Ltd. Company Overview 70
5.22.1 Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
5.23 Merlin MD Pte. Ltd. Company Overview 75
5.23.1 Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
5.24 Metactive Medical, LLC Company Overview 77
5.24.1 Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.25 MicroPort Scientific Corporation Company Overview 78
5.25.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 78
5.26 MicroVention, Inc. Company Overview 82
5.26.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.27 MindFrame Inc. (Inactive) Company Overview 84
5.27.1 MindFrame Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Neuravi Limited Company Overview 85
5.28.1 Neuravi Limited Pipeline Products & Ongoing Clinical Trials Overview 85
5.29 NeuroInterventional Therapeutics, Inc. Company Overview 88
5.29.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.30 NeuroInterventions Company Overview 89
5.30.1 NeuroInterventions Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 NeuroSigma, Inc. Company Overview 90
5.31.1 NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 Neurosyntec LLC. Company Overview 91
5.32.1 Neurosyntec LLC. Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 NexGen Medical Systems, Inc. Company Overview 94
5.33.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.34 NSVascular, Inc. Company Overview 95
5.34.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.35 Palmaz Scientific, Inc. Company Overview 97
5.35.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.36 Penumbra, Inc. Company Overview 98
5.36.1 Penumbra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.37 Philips Healthcare Company Overview 100
5.37.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 100
5.38 PhotoThera, Inc. Company Overview 102
5.38.1 PhotoThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.39 Pulsar Vascular, Inc. Company Overview 110
5.39.1 Pulsar Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.40 Pulse Therapeutics, Inc. Company Overview 111
5.40.1 Pulse Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.41 Rapid Medical Company Overview 112
5.41.1 Rapid Medical Pipeline Products & Ongoing Clinical Trials Overview 112
5.42 Reverse Medical Corporation Company Overview 113
5.42.1 Reverse Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 113
5.43 Rontis AG Company Overview 116
5.43.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 Sequent Medical, Inc. Company Overview 117
5.44.1 Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.45 Shape Memory Therapeutics, Inc. Company Overview 121
5.45.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.46 Silk Road Medical, Inc. Company Overview 123
5.46.1 Silk Road Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.47 Strategic Polymer Sciences, Inc Company Overview 127
5.47.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Stryker Corporation Company Overview 128
5.48.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 128
5.49 Synaptive Medical Inc. Company Overview 133
5.49.1 Synaptive Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.50 Terumo Corporation Company Overview 137
5.50.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 Triticum Medical Ltd. Company Overview 139
5.51.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 139
5.52 Twin Star Medical, Inc. Company Overview 140
5.52.1 Twin Star Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
5.53 University of California, San Francisco Company Overview 142
5.53.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 142
5.54 University of Oxford Company Overview 144
5.54.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 144
5.55 University of South Florida Company Overview 145
5.55.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 145
5.56 University of Wisconsin Madison Company Overview 147
5.56.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 University of Wolverhampton Company Overview 150
5.57.1 University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview 150
5.58 Valor Medical, Inc. Company Overview 151
5.58.1 Valor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.59 Vascular Solutions, Inc. Company Overview 152
5.59.1 Vascular Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.60 Viket Medical Corporation Company Overview 154
5.60.1 Viket Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 154
5.61 Zoll Medical Corporation Company Overview 155
5.61.1 Zoll Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 155
6 Interventional Neurology- Recent Developments 157
7 Appendix 189
7.1 Methodology 189
7.2 About GlobalData 191
7.3 Contact Us 192
7.4 Disclaimer 192
【レポート販売概要】
■ タイトル:世界の神経インターベンション装置開発動向:医療機器パイプライン分析2015■ 英文:Interventional Neurology - Medical Devices Pipeline Assessment, 2015
■ 発行日:2016年1月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0132EPD
■ 調査対象地域:グローバル
- 世界の肉(ミート)市場:ニュース、イベント動向(2014年3月)Synopsis The report provides a review of the latest news and key events in the global meat market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global meat market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global meat market …
- 防虫剤の世界市場:昆虫種類別、製品種類別Insect repellent is a chemical substance applied to skin, clothing, or other surfaces, which discourages insects from landing or climbing on that surface. Insect repellents are divided into two chemical classes, namely, synthetic chemicals, such as DEET (N, N-diethyl-3-methylbenzamide), picaridin, and plant-derived oils, such as oil of lemon eucalyptus and oil of citronella. Mostly, natural substa …
- 農業用微生物の世界市場:細菌、真菌、ウイルス、原虫In order to cater to the demand for higher food production with increasing agricultural input consumption across the globe, farmers are focusing on boosting crop production and their nutritional value. Agricultural microbials are seen as products that can improve their return on investment. Agricultural microbials perform the essential role of protecting crops from pests and improving their yield. …
- 高級デニム製ジーンズの世界市場2016-2020About Premium Denim Jeans The sales of premium denim jeans were mainly from the specialty stores which is a shift from department stores globally. New trends and product innovation in premium range provide prospects for the market growth over the forecast period. Technavio’s analysts forecast the global premium denim jeans market to grow at a CAGR of 8.09% during the period 2016-2020. [Covered in …
- 配電ユニットの世界市場予測(~2024年)“The power distribution unit market is projected to grow at a CAGR of 7.1% from 2019 to 2024” The power distribution unit market is projected to reach USD 5.2 billion by 2024 from an estimated USD 3.7 billion in 2019, at a CAGR of 7.1% during the forecast period. The rising concerns overpower stability for uninterrupted business operations, rising power distribution unit installations for reducing …
- 世界の非GMO(遺伝子組み換え食品)市場(2014-2018)About GMO GMO stands for genetically modified organism, in this the scientist conducts genetic modification of food plants. Scientists remove one or more genes from the DNA of an organism, such as a bacterium, virus, or animal, and recombine them into the DNA of the plant they want to alter or make genetic changes in the DNA of the crops. As a result, crops become intolerant to most of the herbici …
- 世界のワクチン市場(~2019)The expansion of the global vaccine industry is forecast to reach 1.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 8.6%. Currently, human vaccines account for 81.6% of the global demand while veterinary vaccines have a 18.4% share of the market. China, France, Italy, Japan and the United States represent the largest vaccine markets while th …
- マルチチャネル・キャンペーン管理ソリューションの世界市場Increase in data through different communication channels such as mobile, call centers, emails and websites has driven the multichannel campaign management (MCM) market. The rise in customer expectations for real-time view about cross-channel advertisement and one-to-one personalized experiences with brands drive the demand for innovative marketing campaigns. Digital marketing solutions providers …
- BRIC(ブラジル/ロシア/インド/中国)の切除用内視鏡/レゼクトスコープ(医療機器)市場BRIC Resectoscopes Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Resectoscopes Market Outlook to 2020", provides key market data on the BRIC Resectoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Rigid Resectoscopes and Resectoscopes Electrodes (Monopolar (Disposable and Reusable) Ele …
- IoTデバイスの世界市場:スマート冷蔵庫、スマート照明、スマートAC、スマートウォッチ、スマートサーモスタット、スマートグラスThe Internet-of-Things (IoT) is a network of physical devices that are interconnected through various network technologies. The global market for IoT devices is positively influenced by factors like the changing consumers’ lifestyle and growing preference for technologically advanced products, which results in its profound CAGR of more than 43% by 2019. Recent increase in the number of smart homes …
- ポイントオブケア(PoC)脂質試験の世界市場分析:機器別(ブランド市場規模:ロシュリフロトロン、ロシュコバス b 101、アバクシスピッコロ、アリーアコレステックLDX、サムスンLABGEO、PTSカーディオチェック)、用途別(高脂血症、高トリグリセリド血症、家族性高コレステロール血症、高リポタンパク血症、タンジール病)、動向分析Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period. Furthermore, c …
- パーライト及びバーミキュライトの世界市場動向2014/2015The report presents a thorough study of perlite and vermiculite, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing perlite and vermiculite worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: perlite and vermicu …
- 癌診断の世界市場:種類別(臨床検査、遺伝子検査、画像診断、内視鏡検査)、用途別(乳房、肺、肝臓、頸部、大腸、皮膚)、セグメント予測The global cancer diagnostics market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagn …
- 免疫測定機器/分析装置の世界市場の収益分析:製品別(化学発光、免疫蛍光アナライザー、免疫蛍光分析、放射免疫測定、ELISA)、用途別(腫瘍学、感染症検査、自己免疫疾患)、セグメント予測The global immunoassay instruments/analyzers market was valued at USD 14.7 billion in 2015 and is expected to reach a value of USD 23.3 billion by 2024. The prime factors driving the immunoassay analyzers market growth include constant introduction of advanced products. In addition, growing clinical applications for investigation and diagnosis of various chronic and related infectious diseases is …
- デジタルパソロジーの世界市場分析:製品別(低電力、中電力、高電力)、エンドユーザー別(住宅、商業、工業用)、セグメント予測Global Diesel Genset market is expected to reach USD 21.37 billion by 2022. The presence of a large electricity demand-supply gap owing to increase in demand from of mining, telecom, retail and oil & gas sector, is projected to drive diesel gensets industry. The market for industrial use was valued at USD 3.93 billion in 2014. Industrial Diesel Genset is expected to grow substantially over the for …